Find Poziotinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1092364-38-9, Hm781-36b, Nov120101, Unii-oei6oou6ik, Poziotinib [inn], Nov-120101
Molecular Formula
C23H21Cl2FN4O3
Molecular Weight
491.3  g/mol
InChI Key
LPFWVDIFUFFKJU-UHFFFAOYSA-N
FDA UNII
OEI6OOU6IK

Poziotinib
Poziotinib is an orally bioavailable, quinazoline-based, irreversible pan-epidermal growth factor receptor (EGFR or HER) inhibitor, with potential antineoplastic activity. Upon oral administration, poziotinib inhibits EGFR (HER1 or ErbB1), HER2 and HER4, thereby inhibiting proliferation of tumor cells in which these receptors are overexpressed and/or mutated. EGFRs, cell surface receptor tyrosine kinases upregulated or mutated in a variety of cancer cell types, play key roles in cellular proliferation and survival.
1 2D Structure

Poziotinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one
2.1.2 InChI
InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)
2.1.3 InChI Key
LPFWVDIFUFFKJU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C
2.2 Other Identifiers
2.2.1 UNII
OEI6OOU6IK
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Hm781-36

2. Hm781-36b

2.3.2 Depositor-Supplied Synonyms

1. 1092364-38-9

2. Hm781-36b

3. Nov120101

4. Unii-oei6oou6ik

5. Poziotinib [inn]

6. Nov-120101

7. Hm-781-36b

8. Poziotinib [usan]

9. 1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one

10. 1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one

11. Oei6oou6ik

12. Hm-781-36

13. Nov-1201

14. Mfcd28044290

15. Hm 781-36b

16. 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one

17. 2-propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-

18. 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one

19. 1-[4-({4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidin-1-yl]prop-2-en-1-one

20. 2-propen-1-one, 1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)oxy)-1-piperidinyl)-

21. Hm-78136b

22. Poziotinib [who-dd]

23. C23h21cl2fn4o3

24. Poziotinib (hm781-36b)

25. Gtpl7903

26. Schembl3391764

27. Chembl3545154

28. Dtxsid80148853

29. Ex-a528

30. Hms3673k03

31. Amy24248

32. Bcp08270

33. Who 9736

34. Bdbm50468247

35. Nsc783296

36. Nsc800856

37. S7358

38. Zinc95930125

39. Akos026674078

40. Ccg-264748

41. Cs-3942

42. Db12114

43. Nov 120101

44. Nsc-783296

45. Nsc-800856

46. Sb16882

47. Ncgc00386427-01

48. Ncgc00386427-02

49. Ac-29021

50. As-74851

51. Bp161454

52. Da-47945

53. Hy-15730

54. Sy235762

55. Hm 781-36

56. Ft-0752903

57. A13044

58. J-690026

59. Q27088426

60. 1-(4-((4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl)oxy(piperidin-1-yl)prop-2-en-1-one

61. 1-[4-[4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy]-1-piperidinyl]-2-propene-1-one

2.4 Create Date
2009-01-19
3 Chemical and Physical Properties
Molecular Weight 491.3 g/mol
Molecular Formula C23H21Cl2FN4O3
XLogP35.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass490.0974741 g/mol
Monoisotopic Mass490.0974741 g/mol
Topological Polar Surface Area76.6 Ų
Heavy Atom Count33
Formal Charge0
Complexity684
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty